Alzamend Neuro, Inc. (ALZN) › Weighted Average Diluted SharesAlzamend Neuro, Inc. (ALZN) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2022-04-30: 89.10M2023-04-30: 650.1K2024-04-30: 74.2K2025-04-30: 450.8K2026-04-30: 3.34M3.34M2022-04-30Weighted Average Diluted Shares (shares)2026-04-30Period endedWeighted Average Diluted SharesChange YoYSource filing2026-04-303.34M+640.3%2026-07-22From 2025-05-012025-04-30450.8K+507.8%2026-07-22From 2024-05-012024-04-3074.2K-88.6%2025-07-22From 2023-05-012023-04-30650.1K-99.3%2024-07-30From 2022-05-012022-04-3089.10M—2023-07-27From 2021-05-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)